Page last updated: 2024-08-22

tranylcypromine and Substance Withdrawal Syndrome

tranylcypromine has been researched along with Substance Withdrawal Syndrome in 34 studies

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-199018 (52.94)18.7374
1990's10 (29.41)18.2507
2000's5 (14.71)29.6817
2010's1 (2.94)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumgarten, E; Freudenmann, RW; Gahr, M; Hawlik, AE; Schönfeldt-Lecuona, C1
Fuls, K; Shaikh, W1
Bellon, A; Coverdale, JH1
CASPERSON, P; GARETZ, FK1
SCHIELE, BC1
Brunner, H; Friess, E; Pollmächer, T; Wichniak, A1
Bouvy, PF; Oostervink, F; Touw, DJ1
Eyer, F; Jetzinger, E; Pfab, R; Zilker, T1
Hiramori, T; Tagashira, E; Urano, T; Yanaura, S1
Hiramori, T; Nakao, K; Tagashira, E; Urano, T; Yanaura, S2
Baxter, LR1
Draper, RJ; Griffin, N; Webb, MG1
Hiramori, T; Kuroiwa, Y; Nakao, K; Tagashira, E; Urano, T; Yanaura, S1
Briggs, NC1
Briggs, NC; Jefferson, JW1
Dilsaver, SC; Halle, MT1
Darmani, NA1
Bottlender, R; Erfurth, A; Hoff, P; Möller, HJ1
Albrecht, J; Szelényi, A1
Ho, IK; Iwamoto, ET; Khanna, S; Loh, HH; Shen, F; Way, EL1
Ben-Arie, O; George, GC1
Connor, JD; Drust, EG; Sloviter, RS1
Mazzi, D; Pallanti, S1
Gillman, MA; Lichtigfeld, FJ1
Del Medico, VJ; Dilsaver, SC; Halle, MH1
Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T1
Westermeyer, J1
Sternbach, H1
Absher, JR; Black, DW1
Grahame-Smith, DG; Marshall, I1
Oswald, I1
Vogel, GW1
Sargant, W1

Reviews

2 review(s) available for tranylcypromine and Substance Withdrawal Syndrome

ArticleYear
Sleep, natural and unnatural.
    Proceedings of the Royal Society of Medicine, 1969, Volume: 62, Issue:9

    Topics: Amphetamine; Antidepressive Agents; Barbiturates; Brain Chemistry; Dreams; Electroconvulsive Therapy; Electroencephalography; Ethanol; Eye Movements; Female; Heroin; Humans; Isocarboxazid; Male; Monoamine Oxidase Inhibitors; Neurons; Nialamide; Phenelzine; Protein Biosynthesis; Reserpine; Sleep; Sleep Stages; Sleep, REM; Substance Withdrawal Syndrome; Tranylcypromine

1969
REM deprivation. 3. Dreaming and psychosis.
    Archives of general psychiatry, 1968, Volume: 18, Issue:3

    Topics: Anxiety; Behavior; Depression; Dextroamphetamine; Dreams; Drive; Eye Movements; Hallucinations; Humans; Impulsive Behavior; MMPI; Models, Psychological; Personality; Psychoanalytic Theory; Psychological Tests; Psychoses, Alcoholic; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Sleep Deprivation; Substance Withdrawal Syndrome; Tranylcypromine; Trifluoperazine; Wakefulness

1968

Other Studies

32 other study(ies) available for tranylcypromine and Substance Withdrawal Syndrome

ArticleYear
Tranylcypromine discontinuation symptoms and withdrawal delirium.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:4

    Topics: Antidepressive Agents; Antipsychotic Agents; Delirium; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Substance Withdrawal Syndrome; Tranylcypromine; Treatment Outcome

2013
Tranylcypromine dependence and withdrawal.
    The Australian and New Zealand journal of psychiatry, 2009, Volume: 43, Issue:6

    Topics: Aged; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine

2009
Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:12

    Topics: Adult; Chemical and Drug Induced Liver Injury; Delirium; Female; Humans; Monoamine Oxidase Inhibitors; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Thrombocytopenia; Tranylcypromine

2009
PATIENTS' RESPONSE TO TRANYLCYPROMINE WITHDRAWAL.
    The American journal of psychiatry, 1964, Volume: 121

    Topics: Conduct Disorder; Schizophrenia; Substance Withdrawal Syndrome; Toxicology; Tranylcypromine

1964
THE PARNATE-SPECIFIC PATIENT.
    Minnesota medicine, 1965, Volume: 48

    Topics: Depression; Depressive Disorder; Drug Therapy; Humans; Minnesota; Substance Withdrawal Syndrome; Toxicology; Tranylcypromine

1965
Successful suppression of cataplectic attacks with tramadol.
    Neurology, 2003, Sep-23, Volume: 61, Issue:6

    Topics: Aged; Biogenic Monoamines; Cataplexy; Female; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Morpholines; Narcotics; Reboxetine; Receptors, Opioid; Recurrence; Sleep, REM; Substance Withdrawal Syndrome; Tramadol; Tranylcypromine; Treatment Outcome

2003
[Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Nederlands tijdschrift voor geneeskunde, 2003, Oct-04, Volume: 147, Issue:40

    Topics: Aged; Depressive Disorder; Female; Hospitalization; Humans; Male; Monoamine Oxidase Inhibitors; Secondary Prevention; Substance Withdrawal Syndrome; Tranylcypromine

2003
Withdrawal from high-dose tranylcypromine.
    Clinical toxicology (Philadelphia, Pa.), 2008, Volume: 46, Issue:3

    Topics: Adult; Antidotes; Delirium; Heroin Dependence; Humans; Infusions, Intravenous; Male; Migraine Disorders; Monoamine Oxidase Inhibitors; Physostigmine; Substance Withdrawal Syndrome; Thrombocytopenia; Tranylcypromine

2008
Formation of physical dependence on barbiturates and cerebral monoamines.
    Japanese journal of pharmacology, 1983, Volume: 33, Issue:2

    Topics: alpha-Methyltyrosine; Animals; Barbital; Barbiturates; Biogenic Amines; Body Weight; Brain; Catecholamines; Fenclonine; Humans; Hydroxyindoleacetic Acid; Male; Methamphetamine; Methyltyrosines; Rats; Rats, Inbred Strains; Serotonin; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine; Tyrosine 3-Monooxygenase

1983
Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.
    Life sciences, 1983, Apr-04, Volume: 32, Issue:14

    Topics: alpha-Methyltyrosine; Animals; Barbital; Barbiturates; Dose-Response Relationship, Drug; Humans; Male; Methyltyrosines; Pentylenetetrazole; Propranolol; Rats; Rats, Inbred Strains; Reserpine; Seizures; Serotonin; Substance Withdrawal Syndrome; Tranylcypromine

1983
Effects of propranolol on barbital dependence formation and withdrawal signs.
    Japanese journal of pharmacology, 1983, Volume: 33, Issue:1

    Topics: Animals; Anticonvulsants; Barbital; Barbiturates; Drug Interactions; Humans; Male; Propranolol; Rats; Rats, Inbred Strains; Sleep; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; Tranylcypromine

1983
Reversibility of MAO inhibition.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5

    Topics: Adult; Female; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenelzine; Substance Withdrawal Syndrome; Tranylcypromine

1984
Addiction to tranylcypromine.
    British medical journal (Clinical research ed.), 1981, Aug-01, Volume: 283, Issue:6287

    Topics: Adult; Aged; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine

1981
Specific action of tranylcypromine to precipitate barbital withdrawal convulsions.
    Psychopharmacology, 1982, Volume: 77, Issue:2

    Topics: Animals; Barbital; Barbiturates; Humans; Monoamine Oxidase Inhibitors; Pentylenetetrazole; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome; Tranylcypromine

1982
Tranylcypromine withdrawal: is it more common than we realize?
    Journal of psychiatry & neuroscience : JPN, 1994, Volume: 19, Issue:5

    Topics: Humans; Mental Disorders; Psychiatric Status Rating Scales; Sleep Wake Disorders; Sleep, REM; Substance Withdrawal Syndrome; Tranylcypromine

1994
Abuse of monoamine oxidase inhibitors.
    The American journal of drug and alcohol abuse, 1994, Volume: 20, Issue:1

    Topics: Female; Humans; Male; Phenelzine; Sex Factors; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine

1994
Tranylcypromine withdrawal phenomena.
    Journal of psychiatry & neuroscience : JPN, 1993, Volume: 18, Issue:1

    Topics: Acute Disease; Adult; Cognition Disorders; Depressive Disorder; Female; Humans; Male; Monoamine Oxidase Inhibitors; Substance Withdrawal Syndrome; Tranylcypromine

1993
Withdrawal from chronic cocaine administration causes prolonged deficits in L-tryptophan-induced head-twitch response in mice.
    Life sciences, 1997, Volume: 61, Issue:12

    Topics: Analysis of Variance; Animals; Cocaine; Drug Administration Schedule; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Motor Activity; Opioid-Related Disorders; Serotonin; Stereotyped Behavior; Substance Withdrawal Syndrome; Time Factors; Tranylcypromine; Tryptophan

1997
[Mianserin-induced hypertension 2 weeks after discontinuation of tranylcypromine].
    Der Nervenarzt, 1997, Volume: 68, Issue:7

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cardiomyopathy, Dilated; Depressive Disorder; Drug Administration Schedule; Heart Block; Humans; Hypertension; Male; Mianserin; Middle Aged; Recurrence; Risk Factors; Substance Withdrawal Syndrome; Tranylcypromine

1997
Tranylcypromine abuse associated with an isolated thrombocytopenia.
    Pharmacopsychiatry, 1998, Volume: 31, Issue:6

    Topics: Adult; Antidepressive Agents; Female; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders; Thrombocytopenia; Tranylcypromine

1998
Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
    The Journal of pharmacology and experimental therapeutics, 1976, Volume: 199, Issue:2

    Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hydrazines; Iproniazid; Male; Mice; Mice, Inbred ICR; Morphine Dependence; Motor Activity; Naloxone; Pargyline; Substance Withdrawal Syndrome; Time Factors; Tranylcypromine

1976
A case of tranylcypromine ('Parnate') addiction.
    The British journal of psychiatry : the journal of mental science, 1979, Volume: 135

    Topics: Drug Tolerance; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine

1979
Effect of morphine on 'wet-dog' shakes caused by cerebroventricular injection of serotonin.
    Pharmacology, 1979, Volume: 18, Issue:6

    Topics: 5,7-Dihydroxytryptamine; Animals; Brain; Dopamine; Dose-Response Relationship, Drug; Humans; Injections, Intraventricular; Male; Mianserin; Morphine; Naloxone; Norepinephrine; Rats; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome; Tranylcypromine

1979
MDMA (Ecstasy) precipitation of panic disorder.
    Biological psychiatry, 1992, Jul-01, Volume: 32, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Agoraphobia; Alcohol Drinking; Amitriptyline; Arousal; Fluvoxamine; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Panic Disorder; Recurrence; Substance Withdrawal Syndrome; Tranylcypromine

1992
Tranylcypromine abuse: cause for concern?
    The American journal of psychiatry, 1992, Volume: 149, Issue:7

    Topics: Delirium; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine

1992
Symptoms of major depression: acute effect of withdrawing antidepressants.
    Acta psychiatrica Scandinavica, 1991, Volume: 83, Issue:3

    Topics: Adult; Arousal; Chronic Disease; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Substance Withdrawal Syndrome; Tranylcypromine

1991
Neuroleptic malignant syndrome without neuroleptics.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:6

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan

1990
Addiction to tranylcypromine (Parnate): a case report.
    The American journal of drug and alcohol abuse, 1989, Volume: 15, Issue:3

    Topics: Adult; Chronic Disease; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranylcypromine

1989
Danger of MAOI therapy after fluoxetine withdrawal.
    Lancet (London, England), 1988, Oct-08, Volume: 2, Issue:8615

    Topics: Adult; Drug Administration Schedule; Drug Interactions; Female; Fluoxetine; Humans; Substance Withdrawal Syndrome; Tranylcypromine

1988
Tranylcypromine withdrawal delirium.
    Journal of clinical psychopharmacology, 1988, Volume: 8, Issue:5

    Topics: Delirium; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Tranylcypromine

1988
Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice.
    The Journal of pharmacology and experimental therapeutics, 1971, Volume: 179, Issue:3

    Topics: Animals; Body Weight; Brain Chemistry; Drug Interactions; Female; Fenclonine; Humans; Kinetics; Mice; Mice, Inbred Strains; Monoamine Oxidase Inhibitors; Morphine; Morphine Dependence; Motor Activity; Naloxone; Serotonin; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan

1971
Safety of combined antidepressant drugs.
    British medical journal, 1971, Mar-06, Volume: 1, Issue:5748

    Topics: Antidepressive Agents; Dibenzazepines; Drug Synergism; Hallucinations; Humans; Male; Pentobarbital; Psychoses, Alcoholic; Substance Withdrawal Syndrome; Tranylcypromine; Urea

1971